ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01/01/2025
Back to search
Official data from USPTO
RITEDOSE PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RITEDOSE PHARMACEUTICALS
ST13
US500000090136326Class
5
Filing
90136326
Registration
6854964
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
01/02/2025
Trademark type
Word
Nice classes
5
Filing date
08/25/2020
Registration date
09/27/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/27/2022
Last transaction
01/02/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/01/2012
First use in commerce
02/01/2012
Drawing code
4
Owner type
03
Owner location
COLUMBIA, SC
Examiner
ZARICK, DIANA
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
T. C. (pessoa física)
Representatives
THE RITEDOSE CORPORATION
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical oral liquid preparations for the treatment of coldsallergiescoughssinus ailmentsfeversgastrointestinal ailmentsdigestive ailmentscardiovascular ailmentscirculatory ailmentsblood anomaliesrespiratory ailmentsmuscular-skeletal disorderseye disordersoral-ear-nose and throat problemsparasitic problemsendocrine problemsmale and female sexual performance problemsreproductive system problemsurologic and urinary tract problemshormone deficienciesskin disordersinfectionsneurological problemsinsomniahair lossimmunologic ailments; Pharmaceutical oral liquid preparations in the nature of analgesics for pain management; Pharmaceutical oral liquid preparations in the nature of oral contraceptives; Blow fill seal containers for medical use sold filled with pharmaceutical oral liquid preparations for the treatment of coldsallergiescoughssinus ailmentsfeversgastrointestinal ailmentsdigestive ailmentscardiovascular ailmentscirculatory ailmentsblood anomaliesrespiratory ailmentsmuscular-skeletal disorderseye disordersoral-ear-nose and throat problemsparasitic problemsendocrine problemsmale and female sexual performance problemsreproductive system problemsurologic and urinary tract problemshormone deficienciesskin disordersinfectionsneurological problemsinsomniahair lossimmunologic ailments
Publications
History of USPTO decisions and trademark events.
35 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/27/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
09/27/2022
MREI
NOTICE OF REINSTATEMENT E-MAILED
08/26/2022
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
08/25/2022
RGIA
REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
08/25/2022
APET
ASSIGNED TO PETITION STAFF
08/22/2022
ERRS
TEAS REQUEST FOR REINSTATEMENT
08/12/2022
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
06/13/2022
ABN6
ABANDONMENT - NO USE STATEMENT FILED
06/13/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
05/09/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/09/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/14/2021
PUBO
PUBLISHED FOR OPPOSITION
09/14/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/26/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/11/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
08/11/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/11/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
08/11/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/11/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/26/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/26/2021
ALIE
ASSIGNED TO LIE
07/26/2021
NREV
NOTICE OF REVIVAL - E-MAILED
07/19/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/19/2021
PETG
PETITION TO REVIVE-GRANTED
07/19/2021
PROA
TEAS PETITION TO REVIVE RECEIVED
07/19/2021
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
07/12/2021
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
07/12/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/29/2020
GNRT
NON-FINAL ACTION E-MAILED
12/29/2020
CNRT
NON-FINAL ACTION WRITTEN
12/29/2020
DOCK
ASSIGNED TO EXAMINER
12/21/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/28/2020
NWAP
NEW APPLICATION ENTERED
08/28/2020
Continuous trademark protection
Get notified about every new filing that threatens RITEDOSE PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.